Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer

NCT00623064 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride
DRUG: lapatinib ditosylate
OTHER: pharmacological study

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC